“Sounds Great. Do You Want FDA Approval?” A Regulatory Analysis of Psychedelics May 6, 2026 By Charles D. Snow & Kalie E. Richardson & Karla L. Palmer —

https://www.thefdalawblog.com/2026/05/sounds-great-do-you-want-fda-approval-a-regulatory-analysis-of-psychedelics/?utm_source=rss&utm_medium=rss&utm_campaign= We have covered a lot of ground on this blog over the years: Hatch-Waxman disputes, REMS programs, and everything in between. Rarely have we had occasion to write a sentence like this one: A podcast host texted the President of the United States about a Schedule I drug, the President responded, “Sounds great. Do you want FDA approval? Let’s do it,” and FDA is now fast-tracking review of psychedelics.